MYD88 and systemic lupus erythematosus: In addition, upregulated miR-152-3p in SLE CD4+ T cells was involved in the development of SLE by targeting DNMT1 to inhibit myeloid differentiation factor 88 (MyD88) methylation and promote toll-like receptor (TLR)-mediated cellular inflammatory responses (52).